chr8-11757075-G-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001308093.3(GATA4):​c.1141G>A​(p.Val381Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00335 in 1,614,034 control chromosomes in the GnomAD database, including 88 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 31 hom., cov: 33)
Exomes 𝑓: 0.0026 ( 57 hom. )

Consequence

GATA4
NM_001308093.3 missense

Scores

2
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.07
Variant links:
Genes affected
GATA4 (HGNC:4173): (GATA binding protein 4) This gene encodes a member of the GATA family of zinc-finger transcription factors. Members of this family recognize the GATA motif which is present in the promoters of many genes. This protein is thought to regulate genes involved in embryogenesis and in myocardial differentiation and function, and is necessary for normal testicular development. Mutations in this gene have been associated with cardiac septal defects. Additionally, alterations in gene expression have been associated with several cancer types. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0032224953).
BP6
Variant 8-11757075-G-A is Benign according to our data. Variant chr8-11757075-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 377180.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-11757075-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0109 (1662/152346) while in subpopulation AFR AF= 0.0349 (1453/41574). AF 95% confidence interval is 0.0335. There are 31 homozygotes in gnomad4. There are 849 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1662 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GATA4NM_001308093.3 linkuse as main transcriptc.1141G>A p.Val381Met missense_variant 6/7 ENST00000532059.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GATA4ENST00000532059.6 linkuse as main transcriptc.1141G>A p.Val381Met missense_variant 6/71 NM_001308093.3 A1P43694-2

Frequencies

GnomAD3 genomes
AF:
0.0109
AC:
1662
AN:
152228
Hom.:
31
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0351
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00405
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00366
Gnomad SAS
AF:
0.0188
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.00669
GnomAD3 exomes
AF:
0.00521
AC:
1308
AN:
251068
Hom.:
19
AF XY:
0.00551
AC XY:
748
AN XY:
135778
show subpopulations
Gnomad AFR exome
AF:
0.0338
Gnomad AMR exome
AF:
0.00147
Gnomad ASJ exome
AF:
0.00159
Gnomad EAS exome
AF:
0.00348
Gnomad SAS exome
AF:
0.0194
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000176
Gnomad OTH exome
AF:
0.00229
GnomAD4 exome
AF:
0.00257
AC:
3750
AN:
1461688
Hom.:
57
Cov.:
33
AF XY:
0.00293
AC XY:
2131
AN XY:
727136
show subpopulations
Gnomad4 AFR exome
AF:
0.0389
Gnomad4 AMR exome
AF:
0.00170
Gnomad4 ASJ exome
AF:
0.000957
Gnomad4 EAS exome
AF:
0.00798
Gnomad4 SAS exome
AF:
0.0188
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000143
Gnomad4 OTH exome
AF:
0.00386
GnomAD4 genome
AF:
0.0109
AC:
1662
AN:
152346
Hom.:
31
Cov.:
33
AF XY:
0.0114
AC XY:
849
AN XY:
74498
show subpopulations
Gnomad4 AFR
AF:
0.0349
Gnomad4 AMR
AF:
0.00405
Gnomad4 ASJ
AF:
0.00115
Gnomad4 EAS
AF:
0.00367
Gnomad4 SAS
AF:
0.0188
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000265
Gnomad4 OTH
AF:
0.00662
Alfa
AF:
0.00237
Hom.:
4
Bravo
AF:
0.0120
ESP6500AA
AF:
0.0356
AC:
157
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.00626
AC:
760
Asia WGS
AF:
0.0100
AC:
36
AN:
3478
EpiCase
AF:
0.000654
EpiControl
AF:
0.000356

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxOct 07, 2019This variant is associated with the following publications: (PMID: 31513339, 28511407, 26997702, 30766556, 31115957, 26490186, 19678963, 28843068, 18055909, 17352393, 28372585, 16604480, 20981092, 21631294, 22995991, 22011241, 28161810, 21276881) -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesSep 23, 2021- -
Benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsSep 20, 2016- -
Neonatal insulin-dependent diabetes mellitus Benign:1
Likely benign, criteria provided, single submitterresearchClinical Genomics, Uppaluri K&H Personalized Medicine Clinic-Potent mutations in GATA4 gene are associated with neonatal diabetes, decreased insulin production due to pancreatic aplasia or hypoplasia. Also associated with isolated cardiac abnormalities in children, like atrial septal defects. However no sufficient evidence is found to ascertain the role of this particular variant rs114868912 yet. -
Atrioventricular septal defect 4 Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
GATA4-related disorder Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesAug 13, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 17, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.059
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
13
DANN
Benign
0.92
DEOGEN2
Benign
0.24
T;T;T;.;T
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.78
FATHMM_MKL
Benign
0.031
N
MetaRNN
Benign
0.0032
T;T;T;T;T
MetaSVM
Uncertain
-0.037
T
MutationAssessor
Benign
-0.28
.;.;N;.;.
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.23
N;N;N;N;.
REVEL
Uncertain
0.35
Sift
Benign
0.37
T;T;T;T;.
Sift4G
Benign
0.53
T;T;T;T;T
Polyphen
0.0030
.;.;B;.;.
Vest4
0.10
MVP
0.59
MPC
0.16
ClinPred
0.010
T
GERP RS
2.1
Varity_R
0.035
gMVP
0.21

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs114868912; hg19: chr8-11614584; COSMIC: COSV58734960; COSMIC: COSV58734960; API